期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

PET-CT对大肠恶性肿瘤原发病灶的诊断价值分析 被引量：3

下载PDF
导出
摘要 目的探讨PET-CT对大肠恶性肿瘤原发病灶的诊断价值。方法对我院44例经PET-CT检查考虑为大肠恶性肿瘤的患者行结肠镜检查及活检组织病理学检查,以病理学结果为标准进行对比分析。结果经病理组织学检查,诊断为结直肠癌27例、恶性淋巴瘤1例、结肠腺瘤性息肉8例、未见异常8例。结论PET-CT诊断大肠恶性肿瘤灵敏度高、假阴性率低。但由于肠道本身的生理摄取、炎症、息肉等良性病变可致FDG-PET高摄取使之假阳性率较高。因此当肠道出现阳性显像时,不可轻易作出恶性肿瘤的诊断,而应行肠镜检查以明确病变性质。
作者 徐国良 樊卫 罗广裕 高晓燕 张蓉 黎建军 李茵 单宏波
机构地区 华南肿瘤学国家重点实验室 中山大学肿瘤防治中心内镜科 中山大学肿瘤防治中心核医学科
出处 《现代消化及介入诊疗》 2009年第1期43-44,共2页 Modern Interventional Diagnosis and Treatment in Gastroenterology
关键词 PET-CT 结直肠癌 诊断价值分析
分类号 R735.34 [医药卫生—肿瘤] R735.7 [医药卫生—临床医学]
  • 相关文献

参考文献6

  • 1Fr(o)hlich A,Diederichs CG,Staib L,et al.Detection of liver metas-tases from pancreatic cancer using FDG PET.J Nucl Med,1999,40:250-255. 被引量：1
  • 2温广华,邓候富.18F-FDG PET显像在大肠癌诊治中的应用[J].中国普外基础与临床杂志,2004,11(2):180-181. 被引量：2
  • 3Abdel-Nabi H,Doerr RJ.Lamonica DM,et al.Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET:correlation with histopathologic and CT findings.Radi-ology,1998,206:755-760. 被引量：1
  • 4Staib L,Schirrmeister H,Reske SN,et al.Is 18F-fluorodeoxyglucose positron emission tomography in recurrent coiorectal cancer a con-tribution to surgical decision making?Am J Surg.2000.180:1-5. 被引量：1
  • 5丁勇,田嘉禾,卫勃,徐白萱,邵明哲,姚树林,尹大一,张书文,刘雁翎.^(18)FDG-PET在直肠、结肠癌诊断中的价值初探[J].同位素,2006,19(3):146-149. 被引量：9
  • 6Friedland S,Soetikno R,Carlisle M,et al.18-Fluorodeoxyglucose positron emission tomography has limited sensitivity for colonic adenoma and early stage colon cancer.Gastrointest Endosc,2005,61:395-400. 被引量：1

二级参考文献11

  • 1田嘉禾.临床正电子断层成像图谱[M].北京：中国协和医科大学出版社,2002.224-231. 被引量：3
  • 2ECKHART W, BIANCA B, ANDR EASH, et al.Positron Emission Tomogra-phy(PET) for Staging and Evaluation of Response to Treatment in Patients With Hodgkin's Disease[J]. Leukemia and Lymphoma, 1999, 34: 545. 被引量：1
  • 3ROHREN EM, TURKINGTON TG, COLEMAN RE. Clinical Applications of PET in Oncology[J].Radiology, 2004, 231(2):305-332. 被引量：1
  • 4STAHL A, OTT K, WEBER WA, et al. FDG PET Imaging of Locally Advanced Gastric Carcinomas: Correlation With Endoscopic and Histopathological Findings[J] . Eur J Nucl Med Mol Imaging,2003, 30(2): 288. 被引量：1
  • 5FRIEDLAND S, SOETIKNO R, CARIASI.E M,et al. 18-Fluorodeoxyglucose Positron Emission Tomography Has Limited Sensitivity for Colonic Adenoma and Early Stage Colon Cancer[J]. Gastrointest Endosc,2005, 61(3):395-400. 被引量：1
  • 6LARSON SM, SCHODER H, YEUNG H. Positron Emission" Tomography/Co-mputerized Tomography Functional Imaging of Esophageal and Colorectal Cancer [J]. Cancer, 2004, 10(4) : 243-250. 被引量：1
  • 7THALER K, KANNEGANTI S, KH-AJANCHE E Y, et al. The Evolving Role of Staging Laparoscopy in the Treatment of Colorectal Hepatic Metastasis[J]. Arch Surg, 2005, 140(8): 727-734. 被引量：1
  • 8ABDEI. NABI H,DOERR RJ, LAMONICA S, et al. Staging of Primary Colorectal Carcinomas With Fluorine-18-Fluorodeoxyglucose Whole-Body PET:Correlation With Histopathologic and CT Findings[J]. Radiology, 1998, 206:755-760. 被引量：1
  • 9ZUBELDIA JM, BEDNARCZYK EM, BAKER JG, et al. The Economic Impact of ^18FDG Positron Emission Tomography in the Surgical Management of Colorectal Cancer With Hepatic Metastases[J] .Cancer Biother Radiopharm, 2005, 20 (4):450-456. 被引量：1
  • 10SUSAN H, HENRY WDY, HOMER AM, et al.Whole-body FDG-PET in Patients With Recurrent Colorectal Carcinoma: a Comparative Study With CT[J].Clin Posit Imag, 2000, 3(3): 107-114. 被引量：1

共引文献9

同被引文献29

  • 1孙晓光,修雁,刘建军,施一平,万良荣,黄钢.口服造影剂对胃肠道^(18)F-FDG摄取的研究[J].上海第二医科大学学报,2005,25(12):1253-1256. 被引量：7
  • 2丁勇,田嘉禾,卫勃,徐白萱,邵明哲,姚树林,尹大一,张书文,刘雁翎.^(18)FDG-PET在直肠、结肠癌诊断中的价值初探[J].同位素,2006,19(3):146-149. 被引量：9
  • 3An YS,Yoon JK,Lee MH,et al. False negative F-FDG PET/CT in nonsmall cell lung Cancer bone metastases [ J ]. Clin Nucl Med, 200~,30(3) }20~-?04. 被引量：1
  • 4Antoch G, Kuehl H, Kanja J, et al. Dual-modality PET/CT scan- ning with negative oral contrast agent to avoid artifacts:introduction and evaluation [ J ]. Radiology,2004,230 (3) :879-885. 被引量：1
  • 5Groves AM, Kayani I, Dickson JC, et al. Oral contrast medium in PET/CT: should you or shouldn't you? [ J]. Eur J Nucl Med Mol Imaging, 2005,32 ( 10 ) : 1160 -1166. 被引量：1
  • 6Roedl JB, Prabhakar HB, Mueller PR. Prediction of metastatic dis- ease and survival in patients with gastric and gastr esophageal junc- tion tumors: the incremental value of PET-CT over PET and the clinical role of primary tumor volume measurements[ J]. Academic Radio1,2009 ,16(2) :218-226. 被引量：1
  • 7Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG- PET scan in the assessment of suspected metastatic or recurrent ad- enocarcinoma of the colon and rectum [ J ]. Dis Colon Rectum, 2000,43(6) :759-767. 被引量：1
  • 8Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. Detection ot recur- rent and metastatic colorectal cancer: comparison of positron emis- sion tomography and computed tomography [ J ]. Ann Surg Oncol, 1997,4(8) :613-620. 被引量：1
  • 9Kinkel K, Lu Y, Both M, et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods ( US, CT, MR imaging, PET ) : a meta-analysis [ J ]. Radiol- ogy ,2002,224( 3 ) :748-756. 被引量：1
  • 10Nakamoto Y, Togashi K, Kaneta T, et al. Clinical value of whole- body FDG-PET for recurrent gastric cancer: a multicenter study [ J]. Jpn J Clin Oncol,2009,39(5 ) :297-302. 被引量：1

引证文献3

二级引证文献10

现代消化及介入诊疗
2009年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部